Cargando…
Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project
Ovarian cancer is a silent killer and, due to late diagnosis, the primary cause of death amongst gynecological cancers, killing approximately 376 women annually in Denmark. The discovery of a specific and sensitive biomarker for ovarian cancer could improve early diagnosis, but also treatment, by pr...
Autores principales: | Hentze, Julie L., Høgdall, Claus, Kjær, Susanne K., Blaakær, Jan, Høgdall, Estrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898550/ https://www.ncbi.nlm.nih.gov/pubmed/29696206 http://dx.doi.org/10.1016/j.conctc.2017.10.003 |
Ejemplares similares
-
The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis
por: Ingerslev, Kasper, et al.
Publicado: (2017) -
The prevalence of EBV and CMV DNA in epithelial ovarian cancer
por: Ingerslev, Kasper, et al.
Publicado: (2019) -
YKL-40 tissue expression and plasma levels in patients with ovarian cancer
por: Høgdall, Estrid VS, et al.
Publicado: (2009) -
DNA Methylation in Ovarian Tumors—a Comparison Between Fresh Tissue and FFPE Samples
por: Oliveira, Douglas V.N.P., et al.
Publicado: (2021) -
High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population
por: Ingerslev, Kasper, et al.
Publicado: (2016)